LRRC25 Is a Potential Biomarker for Predicting Immunotherapy Response in Patients with Gastric Cancer
Digestive Diseases and Sciences · 2025-04 · 70 (4) · 1395-1410
DOI: 10.1007/s10620-025-08882-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive Diseases and Sciences, online erschienen am 17.02.2025. Verfasst von Zhensong Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, No. 20, Yuhuangding East Road, Zhifu Distri…. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Immunotherapy, Membrane Proteins, Stomach Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Yantai Yuhuangding Hospital, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
BACKGROUND: Leucine-rich repeat containing 25 (LRRC25) is distinguishingly expressed in different tumor types, but the relationship with immune cell infiltration in gastric cancer stills unclear. We analyzed LRRC25 expression using pan-cancer data from The Cancer Genome Atlas and gene data from Gene Expression Omnibus. The clinical significance was further evaluated using gastric cancer tissues derived from clinical trials (no. NCT04208347). METHOD: Through bioinformatics analysis of TCGA database and the UCSC Xena database, we found the correlation between LRRC15, gastric cancer, and immune cell infiltration. Further, multiplex immunohistochemistry/immunofluorescence (mIHC/IF), tissue microarray, and image acquisition and quantitative analysis confirmed our theory. RESULTS: It was discovered that LRRC25 was highly expressed in gastric cancer. Further analysis revealed that the expression of LRRC25 associated with gene sets implicated in immunity, including those in innate immunity, adaptive immunity, and chemokine signaling pathways. The result of (mIHC/IF) suggests a negative relevance between LRRC25 and response of anti-PD-1 treatment and reveals a trend of consistent change on LRRC25 + cells and CD16 expression. We also discovered that LRRC25 expression significantly associated with immune cell infiltration level. In particular, there is a relationship between LRRC25 and the phenotype and function of NK cells. CONCLUSION: High LRRC25 expression contributes to immunosuppressive microenvironment by influencing chemokine axis in gastric cancer. LRRC25 may serve as a clinically useful biomarker for predicting neoadjuvant immunotherapeutic response in patients with gastric cancer. LRRC25 can affect the phenotype and function of NK cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, No. 20, Yuhuangding East Road, Zhifu District, Yantai, 264000, Shandong, China.
- Department of Surgical Department, The Yeda Hospital of Yantai City, Yantai, Shandong, China.
- Department of Gastrointestinal Surgery, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, No. 20, Yuhuangding East Road, Zhifu District, Yantai, 264000, Shandong, China. zhangyifei74@qdu.edu.cn.
Förderung
- Natural Science Foundation of Yantai Yuhuangding Hospital
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Yang, Z., Yu, B., Hu, J., Jiang, L., & Jian, M. (2025). LRRC25 Is a Potential Biomarker for Predicting Immunotherapy Response in Patients with Gastric Cancer. Digestive Diseases and Sciences, 70(4), 1395-1410. https://doi.org/10.1007/s10620-025-08882-7
Vancouver
Yang Z, Yu B, Hu J, Jiang L, Jian M. LRRC25 Is a Potential Biomarker for Predicting Immunotherapy Response in Patients with Gastric Cancer. Digestive Diseases and Sciences. 2025;70(4):1395-1410. doi:10.1007/s10620-025-08882-7
BibTeX
@article{Yang2025,
author = {Yang, Zhensong and Yu, Bin and Hu, Jinchen and Jiang, Lixin and Jian, Mi},
title = {LRRC25 Is a Potential Biomarker for Predicting Immunotherapy Response in Patients with Gastric Cancer},
journal = {Digestive Diseases and Sciences},
year = {2025},
volume = {70},
number = {4},
pages = {1395--1410},
doi = {10.1007/s10620-025-08882-7}
}
EUVIMED